Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies
Fractalkine/CX3CL1, the only member of the CX3C chemokine family, exists as a membrane-anchored molecule as well as in soluble form, each mediating different biological activities. It is constitutively expressed in many hematopoietic and nonhematopoietic tissues such as endothelial and epithelial ce...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2014/480941 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832565051142176768 |
|---|---|
| author | Elisa Ferretti Vito Pistoia Anna Corcione |
| author_facet | Elisa Ferretti Vito Pistoia Anna Corcione |
| author_sort | Elisa Ferretti |
| collection | DOAJ |
| description | Fractalkine/CX3CL1, the only member of the CX3C chemokine family, exists as a membrane-anchored molecule as well as in soluble form, each mediating different biological activities. It is constitutively expressed in many hematopoietic and nonhematopoietic tissues such as endothelial and epithelial cells, lymphocytes, neurons, microglial osteoblasts. The biological activities of CX3CL1 are mediated by CX3CR1, that is expressed on different cell types such as NK cells, CD14+ monocytes, cytotoxic effector T cells, B cells, neurons, microglia, smooth muscle cells, and tumor cells. The CX3CL1/CX3CR1 axis is involved in the pathogenesis of several inflammatory cancer including various B cell malignancies. In tumors the interaction between cancer cells and cellular microenvironment creates a context that may promote tumor growth, increase tumor survival, and facilitate metastasis. Therefore the role of the CX3CL1/CX3CR1 has attracted interest as to the development of potential therapeutic approaches. Here we review the different effects of the CX3CL1/CX3CR1 axis in several inflammatory and neurodegenerative diseases and in cancer, with emphasis on human B cell lymphomas. |
| format | Article |
| id | doaj-art-b163d2895a4c4868a9a93955f6eebbfa |
| institution | Kabale University |
| issn | 0962-9351 1466-1861 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Mediators of Inflammation |
| spelling | doaj-art-b163d2895a4c4868a9a93955f6eebbfa2025-02-03T01:09:35ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/480941480941Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell MalignanciesElisa Ferretti0Vito Pistoia1Anna Corcione2Laboratory of Oncology, Istituto Giannina Gaslini, 16147 Genova, ItalyLaboratory of Oncology, Istituto Giannina Gaslini, 16147 Genova, ItalyLaboratory of Oncology, Istituto Giannina Gaslini, 16147 Genova, ItalyFractalkine/CX3CL1, the only member of the CX3C chemokine family, exists as a membrane-anchored molecule as well as in soluble form, each mediating different biological activities. It is constitutively expressed in many hematopoietic and nonhematopoietic tissues such as endothelial and epithelial cells, lymphocytes, neurons, microglial osteoblasts. The biological activities of CX3CL1 are mediated by CX3CR1, that is expressed on different cell types such as NK cells, CD14+ monocytes, cytotoxic effector T cells, B cells, neurons, microglia, smooth muscle cells, and tumor cells. The CX3CL1/CX3CR1 axis is involved in the pathogenesis of several inflammatory cancer including various B cell malignancies. In tumors the interaction between cancer cells and cellular microenvironment creates a context that may promote tumor growth, increase tumor survival, and facilitate metastasis. Therefore the role of the CX3CL1/CX3CR1 has attracted interest as to the development of potential therapeutic approaches. Here we review the different effects of the CX3CL1/CX3CR1 axis in several inflammatory and neurodegenerative diseases and in cancer, with emphasis on human B cell lymphomas.http://dx.doi.org/10.1155/2014/480941 |
| spellingShingle | Elisa Ferretti Vito Pistoia Anna Corcione Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies Mediators of Inflammation |
| title | Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies |
| title_full | Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies |
| title_fullStr | Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies |
| title_full_unstemmed | Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies |
| title_short | Role of Fractalkine/CX3CL1 and Its Receptor in the Pathogenesis of Inflammatory and Malignant Diseases with Emphasis on B Cell Malignancies |
| title_sort | role of fractalkine cx3cl1 and its receptor in the pathogenesis of inflammatory and malignant diseases with emphasis on b cell malignancies |
| url | http://dx.doi.org/10.1155/2014/480941 |
| work_keys_str_mv | AT elisaferretti roleoffractalkinecx3cl1anditsreceptorinthepathogenesisofinflammatoryandmalignantdiseaseswithemphasisonbcellmalignancies AT vitopistoia roleoffractalkinecx3cl1anditsreceptorinthepathogenesisofinflammatoryandmalignantdiseaseswithemphasisonbcellmalignancies AT annacorcione roleoffractalkinecx3cl1anditsreceptorinthepathogenesisofinflammatoryandmalignantdiseaseswithemphasisonbcellmalignancies |